AU Base Implementation Guide
4.1.0 - Trial Use
This page is part of the AU Base Implementation Guide 4.1.0. It is based on FHIR R4. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Name |
David Goodpatient |
---|---|
DoB | 14 September 1953 |
Gender | Male |
Address | 2 Round Court, QLD 4113 |
Name |
Iam Practitioner |
---|---|
HPI-I | 8003619900015717 |
Phone | 0755501234 |
iam.practitioner@example.com |
Consultation date | 15 Mar 2019 |
---|---|
Consultation summary | Patient presented with weakness over the last couple of days. No other symptoms. Revised patient's medications. Advised patient to see the usual GPs clinic for further consultation and review. |
Medicine | Direction | Medicine Purpose | Medicine Status | Result of Action | Special Instructions |
---|---|---|---|---|---|
Multi-vitamins | 1 tablet daily | New | |||
Spiriva (tiotropium bromide 18mg per inhalation) inhalant | 1 inhalation per day | Chronic Obstructive Pulmonary Disease | Amended | Reduced to one inhalation a day | |
paracetamol 665 mg modified release tablet | Two tablets every 6-8 hours when required. | Osteoarthritis, pain relief | Unchanged | No more than 6 tablets in 24hr | |
cilostazol 100 mg tablet | One a day at night time | Blood thinning | Amended | Form change |
Medicine | Reason |
---|---|
Ibuprofen | Allergic reaction |